Leading biotech company Pharmacyte Biotech Inc (OTCMKTS:PMCB) is known for using high-end technologies to develop drugs for cancer and other diseases….

Plandai Biotechnology Inc (OTCMKTS:PLPL) has reported the signing of an amended deal with USN. As per news from the company, the new deal would allow PLPL…

Medbox Inc (OTCMKTS:MDBX) CEO Jeff Goh sent a letter to founder Mr. Vincent Mehdizadeh wherein he said that as company enters into the next stage of development…

Plandai Biotechnology Inc (OTCMKTS:PLPL) reported that the amended deal with USN will help it to increase its Phytofare® sales to USN and all its related…

Pharmacyte Biotech Inc (OTCMKTS:PMCB) stated that its CEO, Mr. Kenneth L. Waggoner, JD expressed his views on the company’s development plans and talked…

Pharmacyte Biotech Inc (OTCMKTS:PMCB) biotech entity in clinical stage working to advance targeted treatments for patients suffering from diabetes and…

Plandai Biotechnology Inc (OTCMKTS:PLPL) reported that for the quarter ending March 31, 2015, the revenue came at $21,744 against revenues of $12,554 for…

Pharmacyte Biotech Inc (OTCMKTS:PMCB) reported that Chardan Capital Markets LLC, a global investment bank specializing in small, mid-cap and micro firms,…

So far in this year, there are some OTC listed biotech firms that have managed to fetch investors’ attention. One of such company is Pharmacyte Biotech…